Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 10NETWORK 4NIH 3

Study Type

Interventional 3

Sponsor

Cancer Type

Sarcoma 3Lymphoid 3Other hematologic neoplasm 2

Conditions

Leukemia, Myeloid, Acute 61Leukemia 48Precursor Cell Lymphoblastic Leukemia-Lymphoma 33Leukemia, Myelomonocytic, Acute 33Leukemia, Monocytic, Acute 29Congenital Abnormalities 28Leukemia, Erythroblastic, Acute 26Leukemia, Megakaryoblastic, Acute 25Lymphoma 24Myelodysplastic Syndromes 18Burkitt Lymphoma 16Leukemia, Myelomonocytic, Chronic 13Anemia, Refractory, with Excess of Blasts 13Lymphoma, Non-Hodgkin 12Lymphoma, Large B-Cell, Diffuse 12Myeloproliferative Disorders 11Leukemia, Eosinophilic, Acute 11Leukemia, Basophilic, Acute 11Lymphoma, Large-Cell, Immunoblastic 8Lymphoma, Follicular 8Blast Crisis 8Leukemia, Myeloid, Chronic-Phase 7Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7Lymphoma, Mantle-Cell 6Leukemia, Promyelocytic, Acute 6Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Myelodysplastic-Myeloproliferative Diseases 5Leukemia, Lymphocytic, Chronic, B-Cell 5Leukemia, Biphenotypic, Acute 5

Interventions

Cyclophosphamide 7Etoposide 6fludarabine phosphate 5Methotrexate 5Filgrastim 5Vincristine 4Rituximab 4Radiotherapy 4Peripheral Blood Stem Cell Transplantation 4Antilymphocyte Serum 4Methylprednisolone 3Ifosfamide 3Doxorubicin 3Cytarabine 3Busulfan 3aldesleukin 2Vorinostat 2Prednisone 2Oxaliplatin 2Mycophenolic Acid 2Mercaptopurine 2Melphalan 2Dexamethasone 2Daunorubicin 2Cyclosporine 2Asparaginase 2trioctyl phosphine oxide 1sargramostim 1pevonedistat 1obatoclax 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
NIH × Dendritic Cell Sarcoma, Interdigitating × Cytarabine × Clear all
NCT00003423 2013-12-19

Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma

National Cancer Institute (NCI)

Phase 3 Unknown
100 enrolled
LymphoidSarcoma

Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT00058461 2013-10-08

Combination Chemotherapy and Rituximab in Treating Young Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Acute Lymphoblastic Leukemia

National Cancer Institute (NCI)

Phase 2 Terminated
82 enrolled
LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Lymphoma, Large B-Cell, Diffuse, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

NCT00018954 2012-02-20

Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia and Diffuse Non-Hodgkin's Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
LymphoidOther hematologic neoplasmSarcoma

Burkitt Lymphoma, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡